NICE suggest that urological cancer Multidisciplinary teams should assign a risk category to all newly diagnosed men with localised prostate cancer
This is based on the PSA, Gleason score and clinical stage of the prostate cancer.
PSA | Gleason score | Clinical stage | |||
Low risk | < 10 ng/ml | and | <= 6 | and | T1-T2a |
Intermediate risk | 10-20 ng/ml | or | 7 | or | T2b-T2c |
High risk* | > 20 ng/m | or | 8-10 | or | T3-T4 |
*High-risk localised prostate cancer is also included in the definition of locally advanced prostate cancer.
Notes:
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.